JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia

BACKGROUND: The JAK2 V617F mutation has been noted in the cases of polycythemia vera, essential thrombocythemia, and primary myelofibrosis patients. This mutation occurs less frequently in acute myeloid leukemia (AML) and other hematologic diseases, such as myelodysplastic syndrome (MDS); myelodyspl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jekarl, Dong Wook, Han, Sang Bong, Kim, Myungshin, Lim, Jihyang, Oh, Eun-Jee, Kim, Yonggoo, Kim, Hee-Je, Min, Woo-Sung, Han, Kyungja
Formato: Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983014/
https://www.ncbi.nlm.nih.gov/pubmed/21120162
http://dx.doi.org/10.5045/kjh.2010.45.1.46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983014/
https://www.ncbi.nlm.nih.gov/pubmed/21120162
http://dx.doi.org/10.5045/kjh.2010.45.1.46

Ejemplares similares